PLYX
Polaryx Therapeutics, Inc. Common Stock
NASDAQ: PLYX · HEALTHCARE · BIOTECHNOLOGY
$5.22
-7.28% today
Updated 2026-04-29
Market cap
$247.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$2 – $49
Volume
1.1M
Polaryx Therapeutics, Inc. Common Stock (PLYX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | $-173000.00 | $-2.57M | $-3.94M |
| Capital expenditures | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — |
| Stock-based comp | $3.24M | $2.40M | $4.72M |
| Free cash flow | $-173000.00 | $-2.57M | $-3.94M |
| Investing cash flow | — | — | — |
| Financing cash flow | — | — | — |
| Dividends paid | — | — | — |
| Share repurchases | — | — | — |
| Debt repayment | — | — | — |
| Net change in cash | — | — | — |